These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12379629)

  • 21. Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.
    Am J Health Syst Pharm; 2002 Feb; 59(3):225-6. PubMed ID: 11862629
    [No Abstract]   [Full Text] [Related]  

  • 22. Anakinra treatment of patients with rheumatoid arthritis.
    Calabrese LH
    Ann Pharmacother; 2002; 36(7-8):1204-9. PubMed ID: 12086555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].
    Gabay C
    Rev Med Suisse Romande; 2000 Jun; 120(6):529-33. PubMed ID: 11014098
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
    Nuki G; Bresnihan B; Bear MB; McCabe D;
    Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist].
    Rau R; Sander O; Musikic P
    Z Rheumatol; 1998 Oct; 57(5):312-9. PubMed ID: 9864837
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy.
    Cohen SB; Strand V; Aguilar D; Ofman JJ
    Rheumatology (Oxford); 2004 Jun; 43(6):704-11. PubMed ID: 14997006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.
    den Broeder AA; de Jong E; Franssen MJ; Jeurissen ME; Flendrie M; van den Hoogen FH
    Ann Rheum Dis; 2006 Jun; 65(6):760-2. PubMed ID: 16269431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anakinra for flares of pyogenic arthritis in PAPA syndrome.
    Dierselhuis MP; Frenkel J; Wulffraat NM; Boelens JJ
    Rheumatology (Oxford); 2005 Mar; 44(3):406-8. PubMed ID: 15637033
    [No Abstract]   [Full Text] [Related]  

  • 30. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
    Bresnihan B
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anakinra for arthritis.
    Pestell K
    Trends Pharmacol Sci; 2001 Aug; 22(8):401. PubMed ID: 11478998
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anakinra (Kineret) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2002 Feb; 44(1124):18-9. PubMed ID: 11856953
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases].
    Sohen S
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():673-6. PubMed ID: 15035207
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al.
    Martinez-Taboada VM; Fontalba A; Blanco R; Fernández-Luna JL
    Arthritis Rheum; 2005 Jul; 52(7):2226-7. PubMed ID: 15986356
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anakinra in the treatment of rheumatoid arthritis].
    Loft AG; Tarp U; Thomsen BS
    Ugeskr Laeger; 2003 Sep; 165(39):3720-4. PubMed ID: 14558384
    [No Abstract]   [Full Text] [Related]  

  • 38. Erosion healing in rheumatoid arthritis after anakinra treatment.
    Rau R; Sander O; Wassenberg S
    Ann Rheum Dis; 2003 Jul; 62(7):671-3. PubMed ID: 12810433
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel therapies for treatment of rheumatoid arthritis.
    Piascik P
    J Am Pharm Assoc (Wash); 1997; NS37(1):14-6. PubMed ID: 9040165
    [No Abstract]   [Full Text] [Related]  

  • 40. Using anakinra for adult rheumatoid arthritis.
    Kastanek L
    Nurse Pract; 2002 Apr; 27(4):62-5. PubMed ID: 11984420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.